North America leads due to robust healthcare systems, early adoption, and reimbursement strength
And will oral GLP-1s really change adherence and scale, or are injectables here to stay
J., Dmarco, L., Castelao, A
Daily oral doses of high levels (~100 mg l-carnitine/kg body weight) of this compound are routinely employed in the treatment of organic acidemias and primary carnitine uptake deficiency (OMIM212140) and less frequently in the treatment of multiple other IEMs including, but not limited to, urea cycle defects, fatty acid oxidation disorders, mitochondrial disease, maple syrup urine disease (OMIM248600), and lysinuric protein intolerance (OMIM222700) (Mori et al
Cost and equitable access are ongoing challenges
The samples were first loaded onto a Trap C18 column (100 m 20 mm, 5 m) and then separated on a C18 analytical column (75 m 150 mm, 3 m) using a gradient elution method at a flow rate of 300 nL/min